Home » Akonni

Akonni

Aug 21, 2018

Akonni Biosystems Scores $3M NIH Grant for POC Dx Platform, Drug-Resistant TB Assay

The firm plans to make the molecular testing system accessible to low-income countries, in part by reducing costs using reel-to-reel manufacturing.

Mar 20, 2018

Akonni Biosystems Forms Chinese Commercialization Partnership with Righton

The exclusive two-way licensing deal also allows Akonni to commercialize Righton's molecular diagnostic tests outside of China.

Nov 14, 2017

Akonni Wins $300K NIH Grant for Drug-Resistant Tuberculosis Test

The grant was awarded under a program designed to help small businesses transition NIH-funded projects into the commercialization stage.

Aug 09, 2017

Akonni Biosystems Wins NIH SBIR Grant for Pediatric Respiratory Disease Diagnostics

The grant is specifically intended to support the development of noninvasive, rapid tests that can be used at the point of care in developing country settings.

May 15, 2017

Akonni Biosystems Raises $4M

The funding will be used in part to prepare an FDA submission for a clinical IVD pharmacogenomic test for its TruDx 2000 microarray platform.

Jan 09, 2015

Study Suggests Feasibility of Immune-Response Biomarker Panels to Detect Latent Tuberculosis

Premium

An RT-qPCR-based assay of antigen-stimulated blood is a possible next-gen approach for latent TB detection, a Cepheid executive noted in an accompanying commentary.

Jun 24, 2014

IP Roundup: Siemens, Affymetrix, Akonni, University of California, LLNL

Premium

Title: Biochip
Patent Number: 8,753,874
Filed: Dec. 15, 2003
Lead Inventor: Walter Gumbrecht, Siemens

Mar 13, 2014

Harvard, Akonni Partnership Wins $29M to Develop Drug-Resistant Tuberculosis Diagnostic

Premium

Harvard University and Akonni Biosystems have teamed up to develop and test an amplification array-based diagnostic for multi-drug-resistant and extreme-drug-resistant tuberculosis.

Mar 11, 2014

NIAID Awards $12.3M for Dx-Focused Translational Research Centers at Columbia, Harvard

NEW YORK (GenomeWeb News) – Harvard Medical School and Columbia University have both received grants from the National Institute of Allergy and Infectious Diseases, totaling $12.3 million this year, to create translational research centers to develop molecular diagnostics technologies.

Dec 11, 2013

IP Watch: Bio-Rad, Canon US Life Sciences, Akonni, Biological Dynamics, Others Win US Patents

Premium

Biological Dynamics has been awarded US Patent No. 8,603,791, "Nucleic acid sample preparation."

Pages

The Scan

Silencing for Preeclampsia

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

Settlement Expected in Duke Case

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

This Week in PNAS

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

Something Different

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.